Clinical Trials Logo
  1. Home
  2. Other
  3. NCT06385977
  4. Details
NCT06385977 Clinical Trial

Risk Factors for Chronic Prostatitis Patients in Northwest China

Chronic Prostatitis With Chronic Pelvic Pain Syndrome Clinical Trial

Official title:
Risk Factors for Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients in Northwest China

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06385977
Other study ID # ShaanxiPPH
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 2016
Est. completion date June 2024

Study information
Verified date August 2023
Source Shaanxi Provincial People's Hospital
Contact Qian Deng, Doctor
Phone 86-029-85251331
Email dengqian@xiyi.edu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this observational study is to learn about the risk factors of lifestyle, medication and sexual habits in adult chronic prostatitis / chronic pelvic pain syndrome patients. The main questions it aims to answer are: - Is lifestyle, medication, and sexual habits related to chronic prostatitis / chronic pelvic pain syndrome - Is there any medication available to protect men from chronic prostatitis / chronic pelvic pain syndrome. Participants will: - Independently receive a survey questionnaire on lifestyle, medication, and sexual habits. - Symptomatic individuals will undergo additional prostate fluid examination for diagnosis. Researchers will compare healthy adult males to see if there are differences on lifestyle, medication and sexual habits between the two groups.

Description:

All participants were asked to fill out a questionnaire which was modified based on Zhang Ran's research. The questionnaire contained the following parts: patient's general situation, dietary habits, disease status, medication, lifestyle, sexual habits and NIH-CPSI index (National Institutes of Health Chronic Prostatitis Symptom Index). Furthermore, the patients underwent digital rectal examination, expressed prostatic secretion microscopy and microbial culture, urinalysis, urine microbial culture and transrectal ultrasonography.

Recruitment information / eligibility
Status Recruiting
Enrollment 400
Est. completion date June 2024
Est. primary completion date May 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - (1) discomfort or pain in the pelvic region or perineum; (2) symptoms lasting for at least 3 months; and (3) NIH-CPSI pain score of = 4. Controls are volunteers who do not present any prostatitis-related symptoms. Exclusion Criteria: - (1) prostate cancer; (2) benign prostatic hyperplasia with a post-void residual urine volume of >50 ml; (3) acute urinary tract infection.

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• lifestyle
Life habits and personal preferences
• sexual habits
Sexual experience and activities
Drug:
• medication
use of medication

Locations
Country Name City State
China Shaanxi Provincial People's Hospital Xi'an Shaanxi

Sponsors (1)
Lead Sponsor Collaborator
Shaanxi Provincial People's Hospital

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Odds Ratio The ratio of exposed to unexposed individuals in the case group divided by the ratio of exposed to unexposed individuals in the control group baseline
See also
  Status Clinical Trial Phase
Completed NCT04552431 - Chronic Prostatitis Collaborative Research Network Clinical Trial- Ciprofloxacin and Tamsulosin Phase 2
Not yet recruiting NCT05366517 - Repeating LiST for Refractory Non-bacterial Prostatitis/Pelvic Pain Syndrome N/A
Terminated NCT02385266 - Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain Phase 4
Completed NCT00672087 - Diagnostic Challenges in IC (and Male CPPS)
Completed NCT03213938 - Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome N/A
Recruiting NCT00775515 - Laparoscopic Prostatectomy for Chronic Prostatitis Phase 2
Completed NCT01676857 - Chemokine Mechanisms in Chronic Pelvic Pain
Recruiting NCT06299683 - Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment N/A
Completed NCT00826514 - An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis Phase 2
Completed NCT06064448 - Clinical Observation of Ningmitai Capsule in Treating Chronic Pelvic Pain Syndrome With Erectile Dysfunction Phase 4
Completed NCT04446598 - Management of Prostatodynia in Younger Patients With Non-ablative Erbium:YAG Intraurethral Laser N/A
Completed NCT00701311 - An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome Phase 2
Completed NCT04275297 - Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome N/A
Active, not recruiting NCT05075551 - Analyzing the Brain Alterations of Acupuncture on Patients With CP/CPPS Evaluated by fMRI N/A
Completed NCT06016595 - Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients
Active, not recruiting NCT01828996 - Shocking Therapy for Chronic Pelvic Pain Syndrome N/A
Recruiting NCT03629769 - Effects of Proxelan Somministration in Patients With Chronic Prostatitis Phase 3
Recruiting NCT06345014 - The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome Phase 4
Recruiting NCT06115083 - Effects of Pelvic Floor Training in Male Chronic Pelvic Pain, Correlation Between Subjective and Objective Outcomes N/A
Completed NCT03167216 - Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction Early Phase 1